Silva Pharmaceuticals Limited (DSE:SILVAPHL)
Bangladesh · Delayed Price · Currency is BDT 16.80
-0.10 (-0.59%)
At close: Jul 23, 2026
Silva Pharmaceuticals Market Cap
Silva Pharmaceuticals has a market cap or net worth of 2.22 billion as of July 24, 2026. Its market cap has increased by 48.18% in one year.
Market Cap
2.22B
Enterprise Value
2.14B
Revenue
329.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.80
ChartMarket Cap Chart
Since October 10, 2018, Silva Pharmaceuticals's market cap has decreased from 3.77B to 2.22B, a decrease of -40.98%. That is a compound annual growth rate of -6.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2026 | 2.22B | 73.40% |
| Dec 30, 2025 | 1.28B | -7.84% |
| Dec 30, 2024 | 1.39B | -52.78% |
| Dec 28, 2023 | 2.95B | - |
| Dec 29, 2022 | 2.95B | 20.67% |
| Dec 30, 2021 | 2.44B | -2.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The IBN SINA Pharmaceutical Industry | 10.05B |
| Navana Pharmaceuticals | 7.65B |
| Orion Pharma | 6.74B |
| Techno Drugs | 6.24B |
| Indo-Bangla Pharmaceuticals | 2.24B |
| Silco Pharmaceuticals | 2.22B |
| Ambee Pharmaceuticals | 1.94B |
| Pharma Aids | 1.92B |